{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"53","upperLimit":"80","value":"68"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"50"}],"units":"Participants"}],"description":"Percentage of patients with a clinical response following RECIST (Response Evaluation Criteria in Solid Tumors) Criteria: Confirmed complete response(CR), Stable disease (SD), partial response (PR), or without progressive disease (PD).","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients undergo 3 fractions of CyberKnife stereotactic radiosurgery.","id":"OG000","title":"Arm I: CyberKnife Radiosurgery"}],"paramType":"NUMBER","populationDescription":"Intent to treat","reportingStatus":"POSTED","timeFrame":"at 6 months from study entry","title":"Clinical Response Rate","type":"SECONDARY","unitOfMeasure":"percentage of participants"}